introduction to ros in the cardiovascular system john f. keaney, jr., m.d. umass medical school...
TRANSCRIPT
![Page 1: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/1.jpg)
Introduction to ROS inthe Cardiovascular System
John F. Keaney, Jr., M.D.UMass Medical School
Worcester, MA
![Page 2: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/2.jpg)
Role of ROS in CV Disease: Antiquated
NEJM, 1997
![Page 3: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/3.jpg)
Homeostasis
Endogenous Sources
MitochondriaPeroxisomesLipoxygenasesNADPH OxidasesCytochrome P450
AntioxidantDefenses
Enzymatic Systems: CAT, SOD, GPXNon-enzymatic systems: Glutathione Vitamins
Impaired PhysiologicFunction
Impaired PhysiologicFunction
NormalDecreased Repair
Decreased Adaptive Responses
Random Oxidation
Specific SignalPathways
Vascular and MyocardialDisease
Vascular and MyocardialDisease
ROS/RNS
Adapted from Finkel and Holbrook, 2007
![Page 4: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/4.jpg)
NADPH Oxidases
Neutrophil “Burst” Oxidase NADPH Oxidase (Nox) Enzyme Family
Bedard and Krause, Physiol. Rev. 2007;87
![Page 5: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/5.jpg)
Contemporary ROS and CV System:Major Areas of Influence
Cardiac FunctionHypertrophy
AtherosclerosisHypertension
AngiogenesisVascular Repair
![Page 6: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/6.jpg)
Contemporary ROS and CV System:Major Areas of Influence
Cardiac FunctionHypertrophy
AtherosclerosisHypertension
AngiogenesisVascular Repair
![Page 7: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/7.jpg)
NADPH Oxidase (Nox) Enzyme Family
Bedard and Krause, Physiol. Rev. 2007;87
![Page 8: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/8.jpg)
Nox2 Influences Cardiac RemodelingAfter Myocardial Infarction
Hypertension. 2008 Feb;51(2):319-25
• Less pathologic heart remodeling
• Reduced change to the fetal gene program
• Less apoptosis
![Page 9: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/9.jpg)
NADPH Oxidase (Nox) Enzyme Family
Bedard and Krause, Physiol. Rev. 2007;87
![Page 10: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/10.jpg)
Trans Aortic Constriction Model
AorticSuture
WT TAC
![Page 11: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/11.jpg)
Cardiac Nox4 is Deleterious in Pressure Overload
Kuroda J et al. PNAS 2010;107:15565-15570
• Less pathologic hypertrophy
• Improved function (ejection fraction)
• Less apoptosis
![Page 12: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/12.jpg)
Nox4 Impacts Multiple ROS Sources
Kuroda J et al. PNAS 2010;107:15565-15570
![Page 13: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/13.jpg)
Interaction of ROS Sources
Cave et. al. Antioxid. Redox Signal. 8, 691–728
![Page 14: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/14.jpg)
Contemporary ROS and CV System:Major Areas of Influence
Cardiac FunctionHypertrophy
AtherosclerosisHypertension
AngiogenesisVascular Repair
![Page 15: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/15.jpg)
NADPH Oxidase (Nox) Enzyme Family
Bedard and Krause, Physiol. Rev. 2007;87
![Page 16: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/16.jpg)
NADPH Oxidase Activity and Atherosclerosis
• ApoE(-/-) mice with or without p47phox
• Animals on chow followed for 30 weeks
• ROS production measured by DHE staining
• Atherosclerosis determined by aortic lipid content
Barry-Lane et al. J. Clin. Invest. 2001;108:1513
0
50
100
150
RO
SF
lux
(+/+) (-/-)
p47Phox Status
0
2
4
6
Les
ion
(mm
2)
(+/+) (-/-)
p47Phox Status
*
*
*P<0.05
![Page 17: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/17.jpg)
What about hypertension?
![Page 18: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/18.jpg)
Renin-Angiotensin System
![Page 19: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/19.jpg)
NADPH Oxidase (Nox) Enzyme Family
Bedard and Krause, Physiol. Rev. 2007;87
![Page 20: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/20.jpg)
Nox2 and Hypertension
Landmesser, U. et al. Hypertension 2002;40:511-515
• Less ROS produced from blood vessels
• Less rise in blood pressure
• Less vascular hypertrophy
![Page 21: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/21.jpg)
Not all ROS sources are equal!
![Page 22: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/22.jpg)
NADPH Oxidase (Nox) Enzyme Family
Bedard and Krause, Physiol. Rev. 2007;87
![Page 23: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/23.jpg)
BP and Hypertrophy are Distinct
Matsuno, K. et al. Circulation 2005;112:2677-2685
Ang II Infusion
![Page 24: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/24.jpg)
Contemporary ROS and CV System:Major Areas of Influence
Cardiac FunctionHypertrophy
AtherosclerosisHypertension
AngiogenesisVascular Repair
![Page 25: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/25.jpg)
NADPH Oxidase (Nox) Enzyme Family
Bedard and Krause, Physiol. Rev. 2007;87
![Page 26: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/26.jpg)
Bone Marrow Nox2 is Important for Ischemia-Induced Angiogenesis
Urao, N. et al. Circ Res 2008;103:212-220
• Lack of Nox2 impairs ischemia-induced angiogenesis
• This effect is most prominent in bone marrow
![Page 27: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/27.jpg)
Chen et al., PNAS 2004;101:13014-13019
Nox2 Modifies Arterial Injury
IEL
Wild-type, 28d
IEL
Nox2-/- , 28d
Intima:Media
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
39%P=0.036
WT Nox2-/-
![Page 28: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/28.jpg)
How about other ROS Sources?
![Page 29: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/29.jpg)
Mitochondrial ROS are Important for Hypoxic Responses
Guzy et al. , Cell Metabolism, 2005
b
b b
![Page 30: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/30.jpg)
Take Home Points
• ROS are ubiquitous, and serve as cellular messengers
• ROS responses are generally linked to injury and repair responses
• ROS sources and the regulation of these sources has, thus far, proven the most fruitful means of impacting disease
• NADPH oxidases are one important source of ROS in the cardiovascular system
![Page 31: Introduction to ROS in the Cardiovascular System John F. Keaney, Jr., M.D. UMass Medical School Worcester, MA](https://reader036.vdocuments.net/reader036/viewer/2022062518/56649ec95503460f94bd69c7/html5/thumbnails/31.jpg)
What we do not yet know
• Which source(s) of ROS are specific for certain pathologic disorders
• How do the different source(s) of ROS relate to each other
• What are the “normal” mechanisms for specificity of ROS species
• Which ROS/RNS are most important in specific disease(s)